NEW YORK (
CHANGE IN RATINGS
was downgraded at Wunderlich to hold from buy. Valuation call, based on a $56 price target, Wunderlich said.
(BRCM - Get Report)
was downgraded at UBS to neutral from buy. Connectivity headline risk, said UBS. Price target goes to $30.
was downgraded at UBS to neutral from buy. The sale to Land & Buildings is unlikely, said UBS. Price target goes to $55.
(CTXS - Get Report)
was upgraded at Credit Suisse to outperform from neutral. XenMobile and the partnership with Cisco are expected to reaccelerate growth, Credit Suisse said.
was upgraded at Benchmark to buy from hold. $60 price target. The defense backlog is improving in a challenging environment, Benchmark said.
(EA - Get Report)
was initiated with a buy rating and $30.83 price target at Benchmark.
can drive near-term growth, Benchmark said.
was upgraded to buy at TheStreet Ratings.
was upgraded at Wunderlich to buy from hold. $75 price target. Company has competitive advantages, especially in mobile, Wunderlich said.
was upgraded at FBR Capital Markets to market perform from underperform. $32 price target. The outlook is improving in Europe, and investors are favoring industrial names, FBR Capital Markets said.
was downgraded at Cantor Fitzgerald to sell from hold. The loss of two late-stage clinical programs outweighs second-quarter 2013 performance. Price target is $37.
was downgraded at UBS to neutral from buy. Valuation and slowing wireless growth, said UBS. Price target is $40.
(LNKD - Get Report)
was upgraded at Cantor Fitzgerald to buy from hold. $250 price target. Long-term outlook continues to improve, Cantor Fitzgerald said.
was downgraded at UBS to neutral from buy. Reflects breakdown of a potash cartel, said UBS. Price target goes to $40.
was upgraded at Morgan Stanley to overweight from equal-weight. Price target is $41. Management has outlined key future growth opportunities, and the current valuation is attractive, Morgan Stanley said.
Mylan was downgraded at Needham to buy from strong buy. Valuation call, based on a $40 price target, Needham said.